Juvenal Tobin W sold 3,195 shares of CASTLE BIOSCIENCES INC at $35.07 for −$112k on Nov 11, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Chief Commercial Officer
Chief Commercial Officer
Filed Nov 13, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$112,048.65Shares × reported price
Shares traded
3,195Common Stock
Price per share
$35.07Reported price. Read footnotes for ranges.
% of reported position traded
8.89%This security and ownership context
Holdings after
32,737Direct
Trade date
Nov 11, 2026Sell
Filed
Nov 13, 2026, 4:05 PM ET2-day reporting delay
Accession
0001628280-26-073814Code S · Transaction 400508
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 35,932 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 11, 2026Option exercise3,195$0.00$0Trade 400509
Nov 11, 2026Option exercise3,195$29.50$94,252.50Trade 400507
3 transaction rows in this filing. Joint filers share the same rows.

CSTL price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CSTL · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 20, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −5%1w ago +3.6%1d ago −0.2%
Returns since7d30d90d180d1y

Footnotes in full

F1: This transaction was executed in multiple trades at prices ranging from $35.04 to $35.11, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2: The shares subject to the option are fully vested.